What’s Vulnerable › Vulnerabilities

CVE-2021-23233: Fresenius Kabi Agilia Connect Infusion System

• Severity: critical (CVSS 9.8 v3.1)
• Exploited in the wild: not listed in CISA KEV
• EPSS: 0.9% probability of exploitation in the next 30 days
• Public exploit or detection template: none known
• Published: 2022-01-21 · updated 2026-06-17
• Weakness: CWE-284

Description

Sensitive endpoints in Fresenius Kabi Agilia Link+ v3.0 and prior can be accessed without any authentication information such as the session cookie. An attacker can send requests to sensitive endpoints as an unauthenticated user to perform critical actions or modify critical configuration parameters.

Affected products

• Fresenius-Kabi Agilia Connect Firmware: through d25
• Fresenius-Kabi Agilia Partner Maintenance Software: through 3.3.0
• Fresenius-Kabi Link+ Agilia Firmware: before 3.0; 3.0, 3.0-d15 — fixed in 3.0
• Fresenius-Kabi Vigilant Centerium: 1.0
• Fresenius-Kabi Vigilant Insight: 1.0
• Fresenius-Kabi Vigilant Mastermed: 1.0

How to fix

Upgrade to a fixed version: Fresenius-Kabi Link+ Agilia Firmware 3.0. Check the vendor advisory for mitigations.

References

• https://www.cisa.gov/uscert/ics/advisories/icsma-21-355-01
• https://www.cisa.gov/uscert/ics/advisories/icsma-21-355-01

Get alerted when CVE-2021-23233 or the next vulnerability affects your stack